Category: Genetic Counseling

• Remote AI Supported E-Multidisciplinary Oncology Conference in Breast Cancer as a Technology and Method to Optimize Outcomes in the Peripheries.
• Mammas CS, Mamma AS, Papaxoinis G, Georgiou I.
• Stud Health Technol Inform. 2022 Jan 14;289:309-312. doi: 10.3233/SHTI210921.

• PMID: 35062154
• PubMed abstract
• Source abstract

• Free Full Text

• [Two Cases of Hereditary Breast Cancer in Which Genetic Counseling Was Useful].
• Sasaki A, Nagata T, Okamoto Y, Watanabe M, Saida Y.
• Gan To Kagaku Ryoho. 2021 Dec;48(13):1589-1591. Japanese.

• PMID: 35046265
• PubMed abstract
• Source abstract

• Case report. [Article in Japanese]

• Advocating for equitable management of hereditary cancer syndromes.
• Caffrey RG.
• J Genet Couns. 2022 Jan 14. doi: 10.1002/jgc4.1548. Epub ahead of print.

• PMID: 35032082
• PubMed abstract
• Source abstract

• Commentary

• Mainstreaming Genetic Testing for Epithelial Ovarian Cancer by Oncology Providers: A Survey of Current Practice.
• Czekalski MA, Huziak RC, Durst AL, Taylor S, Mai PL.
• JCO Precis Oncol. 2022 Jan;6:e2100409. doi: 10.1200/PO.21.00409.

• PMID: 35025618
• PubMed abstract
• Source abstract

• Brief family history questionnaire to screen for Lynch syndrome in women with newly diagnosed non-serous, non-mucinous ovarian cancers.
• Kim SR, Tone A, Kim R, Cesari M, Clarke B, Hart T, Aronson M, Holter S, Lytwyn A, Maganti M, Oldfield L, Gallinger S, Bernardini MQ, Oza AM, Djordjevic B, Lerner-Ellis J, Van de Laar E, Vicus D, Pugh TJ, Pollett A, Ferguson SE, Eiriksson L.
• Int J Gynecol Cancer. 2022 Jan 10:ijgc-2021-003082. doi: 10.1136/ijgc-2021-003082. Epub ahead of print.

• PMID: 35012974
• PubMed abstract
• Source abstract

• Helix: A Digital Tool to Address Provider Needs for Prostate Cancer Genetic Testing in Clinical Practice.
• Giri VN, Walker A, Gross L, Trabulsi EJ, Lallas CD, Kelly WK, Gomella LG, Fischer C, Loeb S.
• Clin Genitourin Cancer. 2021 Nov 27:S1558-7673(21)00220-2. doi: 10.1016/j.clgc.2021.11.009. Epub ahead of print.

• PMID: 35012874
• PubMed abstract
• Source abstract

• Opinions and experiences of recontacting patients: a survey of Australasian genetic health professionals.
• Vora BB, Mountain H, Nichols C, Schofield L.
• J Community Genet. 2022 Jan 11. doi: 10.1007/s12687-021-00570-z. Epub ahead of print.

• PMID: 35013911
• PubMed abstract
• Source abstract

• Feasibility of personalized screening and prevention recommendations in the general population through breast cancer risk assessment: results from a dedicated risk clinic.
• Saghatchian M, Abehsera M, Yamgnane A, Geyl C, Gauthier E, Hélin V, Bazire M, Villoing-Gaudé L, Reyes C, Gentien D, Golmard L, Stoppa-Lyonnet D.
• Breast Cancer Res Treat. 2022 Jan 7. doi: 10.1007/s10549-021-06445-8. Epub ahead of print.

• Free Full Text

• Hospital-based ovarian cancer patient traceback program results in minimal genetic testing uptake.
• Weinmann S, Phillips S, Sweet K, Cosgrove CM, Senter L.
• Gynecol Oncol. 2022 Jan 5:S0090-8258(21)01695-4. doi: 10.1016/j.ygyno.2021.12.027. Epub ahead of print.

• Source abstract

• Barriers Exist to Cancer Genetic Testing for Black Women, Survey Shows.
• [No author given]
• Inside Precision Medicine. Topics. Oncology. 2022 Jan 5.

• Research news
• Free Full Text

Related:

Original research:

Genetic Counseling and Testing in African American Patients With Breast Cancer: A Nationwide Survey of US Breast Oncologists.

• PMID: 34662201
• PubMed abstract
• Source abstract

• Transgender patients' perspectives on their cancer genetic counseling experiences.
• Rolle L, Zayhowski K, Koeller D, Chiluiza D, Carmichael N.
• J Genet Couns. 2021 Dec 28. doi: 10.1002/jgc4.1544. Epub ahead of print.

• PMID: 34964220
• PubMed abstract
• Source abstract

• A dangerous breast cancer gene mutation changed my life. As a health reporter, I want you to know about it. The PALB2 mutation is lesser-known than BRCA. It’s time to change that.
• Berger S.
• The Lily. (Washington Post). 2021 Dec 27.

• Press
• Free Full Text